טוען...
Epigenetic approaches for chemo-sensitization of refractory diffuse large B-cell lymphomas
Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma (NHL) with the greatest challenge for improving patient survival being the management of chemo-refractory disease upon relapse. Epigenetic dysregulation has been correlated with more aggressive malignancies...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3856881/ https://ncbi.nlm.nih.gov/pubmed/24019329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-13-0358 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|